Page contents Full notification Final report General information GMO characterization European Commission administrative Information Return to search

Full notification Final report - General information Notification Number B-BE-21-BVW3 Member State to which the notification was sent Belgium Date of acknowledgement from the Member State Competent Authority 23/07/2021 Title of the Project Study to Evaluate the Safety and Effects on Progranulin Levels of PR006 in Patients with Fronto-Temporal Dementia with Progranulin Mutations (FTD-GRN). Proposed period of release: 01/09/2021 to 30/04/2028 Name of the Institute(s) or Company(ies) Prevail Therapeutics, Inc., 430 East 29th Street, Suite 1520 New York, NY 10016 USA.
Is the same GMO been notified elsewhere by the same notifier? Yes:
Belgium; Spain; France; Has the same GMO been notified elsewhere by the same notifier? No GMO characterization GMO is a: DNA Virus Identity of the GMO: Genus: DependoparvovirusSpecies: Recombinant AAV9 Information relating to the recipient or parental organisms from which the GMO is derived Common Name: N/A Genus: Dependoparvovirus Species: Adeno-associated virus Subspecies: Strain: AAV9 Pathovar: European Commission administrative Information Consent given by the Member State Competent Authority: Not known